Inflammation, Platelets and Sickle Cell Disease
Launched by UNIVERSITY HOSPITAL, TOULOUSE · Dec 2, 2022
Trial Information
Current as of January 16, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how inflammation and platelets contribute to the symptoms of sickle cell disease (SCD), particularly during painful crises known as vaso-occlusive crises (VOC). SCD is a genetic condition that leads to the formation of misshapen red blood cells, which can block blood flow and cause severe pain and other complications. The researchers want to better understand what happens in the body during these painful episodes to improve treatment options for patients.
To participate in the trial, individuals must be at least 18 years old and have a confirmed diagnosis of sickle cell disease. They also need to be hospitalized for a VOC and able to give written consent for the study. Participants will not be able to take certain medications like aspirin during the trial. If eligible, participants will undergo assessments to help researchers learn more about the role of inflammation and platelets in their condition. This study aims to gather valuable information that could lead to improved care for those living with sickle cell disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient with sickle cell disease diagnosis, hospitalized in emergency department and/or internal medicine department
- • Patient older than 18 years
- • Written consent to participate to the study
- • Patient with health insurance
- • Patient able to receive information about the study
- Exclusion Criteria:
- • Age \< 18 years
- • Non consent to participate to the study
- • Women in pregnancy or breastfeeding
- • Treatment with aspirin or non steroidal anti inflammatory drug
- • Protected patient
- • Patient already involved in a study requiring collection of additional biological samples
Trial Officials
Pierre Cougoul, MD
Principal Investigator
University Hospital, Toulouse
About University Hospital, Toulouse
The University Hospital of Toulouse is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific inquiry with comprehensive clinical services. Its multidisciplinary team of healthcare professionals collaborates with renowned researchers to facilitate pioneering studies across various medical fields, aiming to enhance treatment options and improve patient outcomes. As a prominent institution in the region, the University Hospital of Toulouse is committed to fostering an environment of excellence in both education and research within the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toulouse, , France
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials